1. Home
  2. CPIX vs GROW Comparison

CPIX vs GROW Comparison

Compare CPIX & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • GROW
  • Stock Information
  • Founded
  • CPIX 1999
  • GROW 1968
  • Country
  • CPIX United States
  • GROW United States
  • Employees
  • CPIX N/A
  • GROW N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • GROW Investment Managers
  • Sector
  • CPIX Health Care
  • GROW Finance
  • Exchange
  • CPIX Nasdaq
  • GROW Nasdaq
  • Market Cap
  • CPIX 35.4M
  • GROW 32.9M
  • IPO Year
  • CPIX 2009
  • GROW N/A
  • Fundamental
  • Price
  • CPIX $4.52
  • GROW $2.44
  • Analyst Decision
  • CPIX
  • GROW
  • Analyst Count
  • CPIX 0
  • GROW 0
  • Target Price
  • CPIX N/A
  • GROW N/A
  • AVG Volume (30 Days)
  • CPIX 4.5M
  • GROW 30.5K
  • Earning Date
  • CPIX 03-04-2025
  • GROW 02-12-2025
  • Dividend Yield
  • CPIX N/A
  • GROW 3.66%
  • EPS Growth
  • CPIX N/A
  • GROW N/A
  • EPS
  • CPIX N/A
  • GROW 0.12
  • Revenue
  • CPIX $36,785,442.00
  • GROW $10,008,000.00
  • Revenue This Year
  • CPIX N/A
  • GROW N/A
  • Revenue Next Year
  • CPIX N/A
  • GROW N/A
  • P/E Ratio
  • CPIX N/A
  • GROW $20.22
  • Revenue Growth
  • CPIX N/A
  • GROW N/A
  • 52 Week Low
  • CPIX $1.04
  • GROW $2.38
  • 52 Week High
  • CPIX $6.43
  • GROW $2.95
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 68.47
  • GROW 54.17
  • Support Level
  • CPIX $2.08
  • GROW $2.43
  • Resistance Level
  • CPIX $6.43
  • GROW $2.48
  • Average True Range (ATR)
  • CPIX 0.59
  • GROW 0.04
  • MACD
  • CPIX 0.24
  • GROW 0.00
  • Stochastic Oscillator
  • CPIX 56.09
  • GROW 60.00

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.

Share on Social Networks: